3 completed, 1 terminated. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Pathological Gambling: new trials by email Literature Review of Pathological Gambling trials Research Report on Pathological Gambling
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling olanzapine, sugar pill - Pathological Gambling | Phase 3 | Completed | Lindner Center of HOPE | 42 | 2007-02-01 | 2011-12-13 |
| Topiramate in the Treatment of Pathological Gambling Topiramate, Placebo - Pathological Gambling | Phase 3 | Terminated | Icahn School of Medicine at Mount Sinai | 42 | 2005-10-01 | 2019-07-02 |
| Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling nalmefene HCl, Placebo - Pathological Gambling | Phase 2 / Phase 3 | Completed | Somaxon Pharmaceuticals | 233 | 2005-08-01 | 2008-05-19 |
| Minimal and Brief Treatments for Pathological Gamblers Self-help treatment - Pathological Gambling | Phase 3 | Completed | University of Calgary | 312 | 2003-07-01 | 2009-02-16 |
Gambling (4)
Behavior (4) · Disruptive, Impulse Control, and Conduct Disorders (4) · Mental Disorders (4) · Risk-Taking (4)
Bibliotherapy (1) · Motivational Interviewing (1) · Olanzapine (1) · Sugars (1) · Topiramate (1) · nalmefene (1)
Icahn School of Medicine at Mount Sinai (1) · Lindner Center of HOPE (1) · Somaxon Pharmaceuticals (1) · University of Calgary (1)
United States (2) · Canada (1)
David C Hodgins, PhD. (1) · Eric Hollander, MD (1) · Philip Jochelson, MD (1) · Susan L McElroy, MD (1)